Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$1.3B
52M shares
52-week range
$22.79 – $25.02
99% from low
Sector
FIRE, MARINE & CASUALTY INSURANCE
Exchange
NYSE
CS
Borrow rate
0.26%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $877.1M | $1.01B | $886.9M | $1.08B | $1.10B | $1.13B | $1.13B | $1.10B |
| Cost of revenue | $697.7M | $869.2M | $772.0M | $862.9M | $909.9M | $935.3M | $874.9M | $665.4M |
| Gross profit | $179.4M | $140.7M | $114.8M | $212.6M | $191.9M | $195.1M | $253.3M | $432.6M |
| Gross margin | 20.5% | 13.9% | 13.0% | 19.8% | 17.4% | 17.3% | 22.5% | 39.4% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $29.0M | −$28.8M | −$217.1M | $146.6M | −$6.2M | −$39.1M | $63.1M | $72.1M |
| EBITDA | $66.4M | $6.5M | −$180.2M | $203.6M | $52.2M | $10.0M | $103.2M | $106.6M |
| Net income | $47.1M | $1.0M | −$175.7M | $144.1M | −$402.0K | −$38.6M | $52.7M | $50.9M |
| Net margin | 5.4% | 0.1% | -19.8% | 13.4% | -0.0% | -3.4% | 4.7% | 4.6% |
| EPS (diluted) | 0.88 | 0.02 | -3.26 | 2.67 | -0.01 | -0.73 | 1.03 | 0.99 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $895M | $1.23 | $1.01–$1.62 | 3 |
| 2027 | $876M | $1.25 | $0.95–$1.70 | 3 |
| 2028 | $825M | $1.75 | $1.63–$1.82 | 1 |
Forward consensus · source: Financial Modeling Prep
ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in four segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&C activities, followed by Worker's Compensation.
www.proassurance.comNo one on the platform currently holds PRA.
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2025-09-30 | 323,700 | $7.8M |
| Execution date | Ratio |
|---|---|
| 2012-12-28 | 2-for-1 |
No one on the platform has traded PRA yet.
| $1.8B |
| — |
| HIVEHIVE Digital Technologies Ltd. | $3.76 | -6.70% | $1.0B | — |
| MHLAMaiden Holdings, Ltd. 6.625 NT 2046 | $10.85 | +2.36% | $940M | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$PRA reported 0.25 EPS and 223.51 revenue for Q1. http://www.estimize.com/intro/pra?chart=historical&metric_name=eps&utm_content=PRA&utm_me
View on StockTwits ↗$PRA beats — and it’s all about execution. Q4 EPS came in at 82 cents, topping estimates as expenses declined and investment income rose, even with lower premiums. That’s margin discipline showing up in the numbers. Can expense control keep driving upside here? Get the full breakdown 👉 https://www.zacks.com/stock/news/2875293/proassurance-q4-earnings-beat-estimates-on-declining-expenses?cid=sm-stocktwits-2-2875293-teaser-35165&ADID=SYND_STOCKTWITS_TWEET_2_2875293_TEASER_35165
View on StockTwits ↗$PRA earnings surprise with a 115.8% YoY rise! 🔥 📈 Adjusted operating income of 82 cents per share vs. 22-cent estimate 📉 Revenue dipped 5.6% YoY but still beat consensus by 3.9% 🔍 Zacks Rank #1 (Strong Buy) underscores bullish sentiment Discover the full story here 👉 https://www.zacks.com/stock/news/2875293/proassurance-q4-earnings-beat-estimates-on-declining-expenses?cid=sm-stocktwits-2-2875293-body-35127&ADID=SYND_STOCKTWITS_TWEET_2_2875293_BODY_35127
View on StockTwits ↗$PRA Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $0.64 up 106.45% YoY • Reported revenue of $269.64M down -7.05% YoY • ProAssurance anticipates closing the merger transaction with The Doctors Company by June 30, 2026, and expects continued pressure on workers' compensation rates for 2026.
View on StockTwits ↗Wall St is expecting 0.21 EPS for $PRA Q1 [Reporting 05/11 AMC] http://www.estimize.com/intro/pra?chart=historical&metric_name=eps&utm_cont
View on StockTwits ↗$PRA is a clinical-stage biotech focused on the central nervous system; its pipeline is in early development, representing a long-duration, high-risk bet.
View on StockTwits ↗Wall St is expecting 0.24 EPS for $PRA Q4 [Reporting 02/23 AMC] http://www.estimize.com/intro/pra?chart=historical&metric_name=eps&utm_cont
View on StockTwits ↗$PRA Share Price: $24.03 Contract Selected: May 15, 2026 $25 Calls Buy Zone: $0.23 – $0.28 Target Zone: $0.39 – $0.48 Potential Upside: 62% ROI Time to Expiration: 182 Days | Updates via https://fxcapta.com/stockinfo/
View on StockTwits ↗$HRTG, $PRA, $HCI: Why these insurers are on fire YTD! $HRTG up 125.5% YTD, boosted by a booming E&S business and strategic growth moves. $PRA surges 50% YTD, driven by premium growth and strategic acquisitions. $HCI jumps 56.5% YTD, leveraging diverse business activities and solid growth scores. Discover what’s fueling their momentum here 👉 https://www.zacks.com/stock/news/2756547/3-pc-insurance-stocks-that-have-rallied-more-than-25-ytd?cid=sm-stocktwits-2-2756547-body-13959&ADID=SYND_STOCKTWITS_TWEET_2_2756547_BODY_13959
View on StockTwits ↗Insurance rally — 3 names up 25%+ YTD $HRTG, $PRA, and $HCI have shrugged off higher catastrophe losses, beating not just their industry but also the Zacks S&P 500 composite and the Finance sector. See the full breakdown here 👉 https://www.zacks.com/stock/news/2756547/3-pc-insurance-stocks-that-have-rallied-more-than-25-ytd?cid=sm-stocktwits-2-2756547-teaser-13954&ADID=SYND_STOCKTWITS_TWEET_2_2756547_TEASER_13954
View on StockTwits ↗$PRA Outstanding article that hits the mark on PRA's current state. So if you want to refresh your PRA insights or learn about PRA from scratch, this is a must read. https://beyondspx.com/quote/PRA/analysis/proassurance-a-disciplined-specialty-insurer-s-strategic-evolution-towards-value-creation-nyse-pra
View on StockTwits ↗$PRA beats Q2 earnings estimates — what drove the surprise? 📈 ProAssurance's adjusted operating income hit 52 cents per share, crushing the Zacks Consensus Estimate of 19 cents, thanks to rising investment income and lower expenses. However, lower premiums in Specialty P&C and Reinsurance segments partially offset gains. Full breakdown here 👉 https://www.zacks.com/stock/news/2698158/proassurance-q2-earnings-beat-estimates-on-declining-expenses?cid=sm-stocktwits-2-2698158-body-7225&ADID=SYND_STOCKTWITS_TWEET_2_2698158_BODY_7225
View on StockTwits ↗$PRA just beat Q2 earnings — here’s the driver you didn’t expect 📈 Lower expenses and higher investment income more than made up for softer premiums, pushing results above estimates. Full breakdown here 👉 https://www.zacks.com/stock/news/2698158/proassurance-q2-earnings-beat-estimates-on-declining-expenses?cid=sm-stocktwits-2-2698158-teaser-7222&ADID=SYND_STOCKTWITS_TWEET_2_2698158_TEASER_7222
View on StockTwits ↗$PRA | Merger Breaks, Stake Increases, and Strategic Sales: Key Developments in SSI's Weekly Update "ProAssurance merger with The Doctors Company faces potential regulatory hurdles, particularly in California, risking a 30-40% stock drop." - Special Situation Investments (Special Situation Investments) Read more: https://www.smartkarma.com/insights/merger-breaks-stake-increases-and-strategic-sales-key-developments-in-ssi-s-weekly-update
View on StockTwits ↗$PRA | Current Active Merger, Acquisition, and Liquidation Opportunities: An Overview "ProAssurance merger with TDC faces potential regulatory hurdles, creating a short opportunity with limited downside and significant upside." - Special Situation Investments (Special Situation Investments) Read more: https://www.smartkarma.com/insights/current-active-merger-acquisition-and-liquidation-opportunities-an-overview
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Trading at 30.1× earnings vs its 13.4× historical median P/E.
Fair value ≈ $11.11 · price $25.00 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.